Budapest, Hungary

Eva Gal


Average Co-Inventor Count = 14.9

ph-index = 1

Forward Citations = 68(Granted Patents)


Company Filing History:


Years Active: 1995-1998

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Eva Gal

Introduction

Eva Gal, a distinguished inventor based in Budapest, Hungary, has made significant contributions to the field of pharmaceuticals through her innovative work. With a remarkable portfolio of three patents, her research focuses on the development of N-benzoylamino acid derivatives. These innovations highlight her commitment to advancing medicinal chemistry and improving drug formulations.

Latest Patents

Eva Gal's latest patents center around N-benzoylamino acid derivatives and related pharmaceutical compositions. Her inventions include novel compounds represented by the formula (I), where modifications in the structure cater to various therapeutic needs. The patents detail compounds wherein R³ is an NR⁴R⁵ group, with options including hydrogen and various alkyl groups. These advancements not only underscore her technical expertise but also contribute to the greater field of pharmaceutical research.

Career Highlights

Throughout her career, Eva has collaborated with prominent companies in the pharmaceutical sector. Notably, she has worked with Gyogyszerkutato Intezet Kft. and Egis Gyogyszergyar Rt., where she honed her skills and expanded her research capabilities. Her dedication to innovation in drug development has positioned her as a respected figure in the industry.

Collaborations

Eva Gal has had the privilege of collaborating with esteemed colleagues, including Peter Matyus and Erzsebet Zara. These partnerships have fostered an environment of creativity and shared knowledge, enhancing the impact of her work on the scientific community.

Conclusion

Eva Gal's contributions to the field of pharmaceutical innovations are marked by her valuable patents and collaborations. Her work not only reflects her individual talent but also signifies the importance of teamwork in driving progress within the industry. As she continues to innovate, Eva remains a key player in the advancement of pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…